Bupropion XR Sandoz 150 mg
Bupropion XR Sandoz 150 mg is a medicine authorised by Swissmedic under authorisation number 68628. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 12 December 2023 and the authorisation is limited until 11 December 2028. ATC code N06AX12 places the medicine in the group Psychoanaleptics.
| Authorisation number | 68628 |
|---|---|
| Name | Bupropion XR Sandoz 150 mg |
| Full name | Bupropion XR Sandoz 150 mg, Retardtabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N06AX12 |
| First authorisation | 12 December 2023 |
| Authorisation validity | 11 December 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bupropion XR Sandoz 150 mg, Retardtabletten | B | 12 December 2023 |
| 2 | Bupropion XR Sandoz 300 mg, Retardtabletten | B | 12 December 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Tablette(n) | N06AX12 | 01.06.0. | B |
| 2 | 30 | Tablette(n) | N06AX12 | 01.06.0. | B |
| 3 | 30 | Tablette(n) | N06AX12 | 01.06.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bupropion XR Sandoz 150 mg authorised in Switzerland?
Yes. Bupropion XR Sandoz 150 mg is authorised by Swissmedic under authorisation number 68628, data as of 01 September 2026. The authorisation is limited until 11 December 2028.
Which dispensing category does Bupropion XR Sandoz 150 mg have?
Bupropion XR Sandoz 150 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Bupropion XR Sandoz 150 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.